Skip to main content
FTH
NASDAQ Life Sciences

Faeth Lands Roche Collaboration to Test PIKTOR With Giredestrant in Breast Cancer

Tom Rudovsky · Reported by BusinessWire
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$10.5
Mkt Cap
$259.215M
52W Low
$7.45
52W High
$42.143
52W Position info
41% above low
Off High info
75% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

FTH sits 41% above its 52-week low of $7.45 on elevated volume (2.1× avg).

Summary

Faeth signed a clinical trial collaboration and supply agreement with Roche to test its lead program PIKTOR alongside Roche's investigational giredestrant in HR+/HER2- advanced breast cancer. Faeth will sponsor and run the Phase 1b/2 study (FTH-PIK-101); Roche supplies the drug, so Faeth takes on the trial cost without paying for the combination agent. The rationale is resistance to endocrine therapy driven by the PI3K/AKT/mTOR pathway, which PIKTOR targets at multiple nodes. This follows the November 9 report of 33% response data for PIKTOR plus paclitaxel in endometrial cancer, and a Big Pharma partner supplying a drug for the breast program adds external validation. First patient in FTH-PIK-101 was dosed in April 2026, with interim data anticipated in 2027.

At the time of this announcement, FTH was trading at $10.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $259.2M. The 52-week trading range was $7.45 to $42.14. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

FTH - Latest Insights

FTH
Nov 09, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $10.20 info
Change: -$12.30 (-55%) info
Market Cap: $259.215M info
FTH
Nov 03, 2026, 8:10 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $19.20
Real-time Price: $10.20 info
Change: -$9.00 (-47%) info
Market Cap: $259.215M info
FTH
Nov 03, 2026, 7:30 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $19.23
Real-time Price: $10.20 info
Change: -$9.03 (-47%) info
Market Cap: $259.215M info
FTH
Aug 17, 2026, 7:31 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $32.44
Real-time Price: $10.20 info
Change: -$22.24 (-69%) info
Market Cap: $259.215M info
FTH
Aug 04, 2026, 7:40 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.00
Real-time Price: $10.20 info
Change: -$19.80 (-66%) info
Market Cap: $259.215M info